Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 156CNS 29Sarcoma 21Thoracic 13Gynecologic 11Tumor-Agnostic 10Genitourinary 8Breast 6Other solid neoplasm 5Endocrine 3Dermatologic 3Lymphoid 2Other hematologic neoplasm 1NET 1Head & Neck 1

Conditions

Sarcoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Glioma 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

venetoclax 309Cyclophosphamide 233Cytarabine 200Azacitidine 192fludarabine 182Specimen Handling 135Biopsy 103fludarabine phosphate 97Methotrexate 82Rituximab 80Daunorubicin 79Dexamethasone 76Vincristine 70Whole-Body Irradiation 65Mycophenolic Acid 60Decitabine 57Tacrolimus 55ibrutinib 52Etoposide 52blinatumomab 51obinutuzumab 50Granulocyte Colony-Stimulating Factor 50Busulfan 50Prednisone 48Melphalan 48acalabrutinib 47Injections 47Stem Cell Transplantation 45Magnetic Resonance Spectroscopy 43Idarubicin 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Irinotecan × Other hematologic neoplasm × 1 year × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡